Brace yourself for three extraordinary days across Abu Dhabi and Dubai at the world’s largest AI community gathering! With an exclusive Summit for global leaders in Abu Dhabi and a thrilling exhibition showcase in Dubai, Ai Everything GLOBAL 2025 brings the best of the AI world to UAE. Be part of the legacy. Secure your pass NOW! – Click Here 📍 4 Feb 2025: Summit … Continue reading AI EVERYTHING GLOBAL – REGISTRATION IS LIVE!
Press Release – January 07, 2025 – BALA CYNWYD, Pa. – VMG Health is pleased to announce its acquisition of Veralon, a national leader in healthcare strategy, finance, valuation, provider compensation, and virtual board education. This strategic move reinforces VMG Health’s position as the premier consultancy dedicated to helping healthcare organizations across the nation achieve and sustain superior business performance. VMG Health is a portfolio company of Incline … Continue reading VMG Health Acquires Veralon®, Healthcare Consulting Firm
Current Renovaro Chairman to Lead Subsidiary’s Development Program and Commercialization Los Angeles and Amsterdam – December 30, 2024 – Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, today announced Chairman of the Board, Maurice van Tilburg, has been appointed as Chief Executive Officer of its subsidiary GEDi Cube BV (a leader in AI-driven cancer diagnostics by integrating multi-omics with liquid biopsies) DBA RenovaroCube. … Continue reading Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV
Press Release – STOCKHOLM & RADNOR, Pa. – Immedica Pharma AB (Immedica), a leading global rare disease company, and Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company committed to improving the lives of patients with seizure disorders, today announced that they have entered into an agreement and plan of merger under which Immedica has agreed to acquire Marinus, by means of a tender offer and subsequent merger. … Continue reading Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.
Proposed merger would add a differentiated Phase 3 TROP2 Antibody-drug Conjugate (ADC) to the combined company’s pipeline PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has entered into a binding term sheet for a proposed merger with Oqory, Inc., a … Continue reading Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.
